Fermentalg
Identification
Instrument name
FERMENTALG
Symbol
FALG
ISIN code
FR0011271600
Exchange / Market
Euronext
Trading location
Paris
Products family
Stocks
Capitalization compartment
Compartment C
ICB
Specialty Chemicals
Activity description
Fermentalg est spécialisé dans la recherche, le développement et la bio-production de molécules chimiques à partir de micro-algues. Les produits sont destinés aux secteurs de l’alimentation, de la pharmacie, de la cosmétique, de la nutrition animale, de la chimie de spécialité et de la bioénergie.
Source : Cofisem
Website address
http://www.fermentalg-bourse.com
Operation
IPO date
Wed 16/04/2014
IPO type
Initial Public offering
Catégorie
IPO
Price range
EUR 7.37 - EUR 9.00
Capital raised
40,4
Company profile
Fermentalg is an expert in the research and bio-industrial exploitation of micro-algae and aims to provide sustainable solutions and innovative products that contribute to the development of healthy, natural and high-performance products. Its business: the development, production and marketing of sustainable solutions and active ingredients derived from microalgae for nutrition, health and the environment. Nutritional lipids, alternative proteins and natural food colorants make up the company's current and future offer.
Source:
Cofisem
-
Last Update:
29 Mar 2025
Key Executives
| Chief Executive Officer | Pierre Josselin | ||||
| Chief Financial Officer | Betrand Devillers | ||||
| Chief Human Resources Officer | Emmanuelle Benitez Cano | ||||
| Chief Market Officer | Marie Jane Fallourd | ||||
| Chief Scientific Officer | Hywel Griffiths | ||||
| Chief Operating Officer | Guillaume Nogaro | ||||
| Director Research & Development | Manuel Rodrigo Rangel | ||||
| Source: Cofisem - Last Update: 29 Mar 2025 | |||||
Key figures
| Millenium | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Net sales | 11.497 | 4.058 | 7.648 | 5.647 | 2.205 |
| Income from ordinary activities | 13.109 | 5.121 | 9.035 | 6.796 | 3.661 |
| Operating income | -9.220 | -11.808 | -9.030 | -5.856 | -6.180 |
| Cost of financial indebtedness net | 36 | 188 | 424 | 640 | 672 |
| Equity-accounted companies contribution to income | -3.117 | -875 | -459 | -321 | |
| Net profit from discontinued activities | |||||
| Net income | -12.876 | -14.148 | -9.874 | -6.850 | -6.878 |
| Net income (Group share) | -12.876 | -14.148 | -9.874 | -6.850 | -6.878 |
| Fiscal year end | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Length of fiscal year (month) | 12 | 12 | 12 | 12 | 12 |
| Currency & Unit | EUR - thousands | EUR - thousands | EUR - thousands | EUR - thousands | EUR - thousands |
| Account Standards | IFRS | IFRS | IFRS | IFRS | IFRS |
| Source: Cofisem - Last Update: 29 Mar 2025 | |||||